Strategic consulting
n-licensing Market Assessment
The marketability of a product is a determining factor in the evaluation of in-licensing opportunities. Our experts can assess the commercial potential of licenses for the Canadian market. Our assessments include a scan of the environment, a critical analysis of clinical data and unmet needs as well as a preliminary estimate of the potential price.
Strategic Market Access Analysis
Our expertise and knowledge of the Canadian market allows us to conduct in-depth analyses of strengths, weaknesses, opportunities and threats from a clinical, pharmacoeconomic and market access perspective. Furthermore, we can help highlight the added value of a product through the development of a global value dossier.
Critical Analysis of Submissions to Payers
To support pharmaceutical companies with drug submissions to the various payers, our expertise makes us the ideal partner for the critical analysis of prepared documents prior to submission as well as the rendered decision notices. On the other side, we can advise private payers in their reimbursement decisions by performing Health Technology Assessments consisting of analyses of both the therapeutic value and cost-effectiveness of the treatment in question.
